• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » A call for CE Mark overhaul grows at this year’s ESC conference | European Society of Cardiology Congress 2011

A call for CE Mark overhaul grows at this year’s ESC conference | European Society of Cardiology Congress 2011

August 31, 2011 By MassDevice staff

European Society of Cardiology

Physicians at this year’s European Society of Cardiology meeting in Paris called for an overhaul of Europe’s CE Mark medical device approval process, calling it too lax in review of potentially dangerous products.

Medical device makers have chided the FDA for inefficient review of new technologies and Congress has asked the watchdog agency to review Europe’s less stringent process for opportunities to revamp the system at home, but doctors had harsh criticism for the CE Mark pathway, saying it uses the same structure to review pacemakers and electric toasters.

Life-saving devices can hit the market faster in Europe where clinical testing is generally done after approval, unlike in the U.S. where high-risk devices more frequently undergo a battery of clinical trials to prove safety and effectiveness prior to being allowed on the market.

“Where there have been isolated instances of devices that were associated with complications, those have disproportionately occurred in countries that have earlier approval — and that tends to be Europe,” Cardiff University cardiologist Dr. Alan Fraser who led a E.U. regulatory review panel at the ESC meeting told Reuters.

M and A Roundup

Here’s a roundup of recent clinical trial and scientific study news from the ESC 2011 conference:

  • More ICD infections means more lead extractions for cardiologists
    As more patients receive  implantable cardioverter defibrillators the number of patients with infections related to their ICDs grows, a situation that is complicated by an increasingly older population with comorbidities and increased heart failure that push infection risks even higher.
  • Confirmed infections require complete removal of all pieces of the device, a procedure done in specialized centers.

    "The extraction is a battle that requires a wonderful general, a great army, and a careful strategy," she said. "And a little bit of good luck in some situations," panel presenter Dr. Maria Grazia Bongiorni of the University Hospital of Pisa, Italy said.

    Read more

  • Ventricular assist devices do more harm than good for high-risk transplant patients
    Patients with urgent but stable heart failure should avoid ventricular assist implants, according to data gathered from the Spanish National Heart Transplant Registry.
    Read more
  • Drug-eluting stents plus antiplatelet therapy make a good team for STEMI patients
    Drug-eluting stents proved better than bare-metal stents in one-year clinical outcomes, including for in-stent thrombosis, target lesion revascularization, and target vessel revascularization.
    Read more
  • Stereotaxis touts magnetic navigation study results
    Stereotaxis, Inc. (NSDQ:STXS) unveiled results from the first-ever, prospective multicenter evaluation of magnetic navigation for ventricular tissue ablation with a 94 percent acute success rate.
    Read more
  • Filed Under: Cardiac Implants, News Well, Replacement Heart Valves, Research & Development Tagged With: European Society of Cardiology Congress, Stereotaxis

    In case you missed it

    • Boston Scientific to build new plant outside Atlanta
    • NovaXS unveils prototype for smart, needle-free drug delivery device
    • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    • SpineX enrolls first patient in spinal neuromodulation technology trial
    • GE Healthcare’s Carescape ventilator battery recall is Class I
    • Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
    • Advanced NanoTherapies closes $7.2M Series A for drug-coated balloon
    • Centerline Biomedical raises $33M Series B
    • How medical device companies are responding to abortion bans
    • Memic completes first robotic-assisted transvaginal hysterectomy procedures with Hominis
    • ‘Multiple disruptions’ slow timeline for Titan Medical’s Enos robotic surgery platform
    • Philips updates on testing results for recalled ventilators
    • Varian wins FDA IDE for Flash radiation therapy
    • Researchers develop wearable robotic exomuscle system
    • Virpax to pursue over-the-counter pathway for topical spray treatment for osteoarthritis pain
    • Inovio names new chief medical officer
    • FDA clears Acutus’ AcQCross system for use with Boston Scientific’s Watchman

    RSS From Medical Design & Outsourcing

    • Philips updates on testing results for recalled ventilators
      Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
    • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
      Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]
    • Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
      Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina. San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight. The flights starting… […]
    • How medical device companies are responding to abortion bans
      Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
    • Boston Centerless opens manufacturing plant in Indiana
      Boston Centerless announced today that it opened a second manufacturing plant in Fort Wayne, Indiana. Woburn, Massachusetts-based Boston Centerless said in a news release that the latest expansion for the supplier of precision ground bar materials for close tolerance CNC Swiss machining applications represents continued robust growth in key market segments in the Midwest and… […]
    • Dymax strikes new partnership with Quantum Systems
      Rapid curing materials and equipment manufacturer Dymax today announced a new sales partnership with Quantum Systems. Torrington, Connecticut-based Dymax said in a news release that Quantum, with its offices in Arizona as well as Sonora and Baja, Mexico, will focus its efforts on promoting and supporting the sales of Dymax light-curing solutions to the medical,… […]
    • Researchers develop wearable robotic exomuscle system
      ETH Zurich researchers have redefined the muscle shirt. Marie Georgarakis, a former doctoral student at ETH Zurich’s Sensory Motor Systems Lab, is the creator of the Myoshirt, a wearable, textile robotic device that helps users lift their arms and reach. A motorized cable works like an artificial tendon, directed by sensors and an algorithm to… […]
    • They said it at DeviceTalks Boston
      Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead. Here are some of the most quotable insights from panelists and speakers at our live event. And make sure to save the date — and save your seat… […]
    • Summer health technology program brings diverse group of interns to Silicon Valley
      Diversity by Doing HealthTech (DxD) is holding a Summer Innovation and Exploration Series for college student interns from underrepresented groups. The series is on its second day today at Fogarty Innovation and Stanford Byers Center for Biodesign — the two organizations that jointly formed and support DxD. The event debuted last year in an online… […]
    • Clippard releases new series of isolation valves
      Clippard (Cincinnati) has Its Clippard NIV Series media isolation valve — a solenoid-operated device using a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves find everyday use in a wide variety of applications. Think uses that require precise, repeatable dispensing of media for analytical instrumentation. Clippard says media isolation… […]
    • Another Medtronic HVAD recall is serious
      A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this… […]

    Leave a Reply

    You must be logged in to post a comment.

    Primary Sidebar

    DeviceTalks Weekly

    June 24, 2022
    How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
    See More >

    MEDTECH 100 INDEX

    Medtech 100 logo
    Market Summary > Current Price
    The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
    Need Medtech news in a minute?
    We Deliver!

    MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

    MDO ad

    Footer

    MASSDEVICE MEDICAL NETWORK

    DeviceTalks
    Drug Delivery Business News
    Medical Design & Outsourcing
    Medical Tubing + Extrusion
    Drug Discovery & Development
    Pharmaceutical Processing World
    MedTech 100 Index
    R&D World

    Device Talks Webinars, Podcasts, & Discussions

    Attend our Monthly Webinars
    Listen to our Weekly Podcasts
    Join our Device Talks Tuesdays Discussion

    MASSDEVICE

    Subscribe to MassDevice E-Newsletter
    Advertise with us
    About
    Contact us
    Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

    Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
    The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

    Advertise | Privacy Policy | RSS